Literature DB >> 1902445

Production and effect of infectious Dane particles in transgenic mice.

K Araki1, S Nishimura, T Ochiya, K Okubo, J Miyazaki, K Matsubara, K Yamamura.   

Abstract

We have demonstrated by immunoelectron microscopy that 42-nm particles with double-shelled structures characteristic of Dane particles are present in the serum of transgenic mice, 1.2HB-BS 10, carrying partly duplicated hepatitis B virus (HBV) genome. Furthermore, these particles were shown to infect primary human fetal hepatocytes as demonstrated by the elevation of HBV surface antigen (HBsAg) in the culture medium. HBV DNA is known to be expressed in a liver- and kidney-specific manner in the adult mouse, so we examined the developmental expression of viral antigens. In the liver, viral antigens (HBsAg and HBV e antigen) began to be expressed before birth and the level of expression showed a sharp rise after birth. On the other hand, in the kidney, viral antigens began to be expressed after birth. Serum levels of viral antigens were roughly proportional to the levels of expression in the liver, suggesting that the liver is the main source for viral antigens in the serum. None of these transgenic mice produced anti-HBs or anti-HBV core response or showed biochemical or pathological change up to at least 24 months of age. All these results suggest that infectious viral particles can be produced in transgenic mice, and that expression and replication of HBV DNA are not toxic in vivo.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902445      PMCID: PMC5918401          DOI: 10.1111/j.1349-7006.1991.tb01834.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  16 in total

Review 1.  Experimental systems for the study of hepadnavirus and hepatitis delta virus infections.

Authors:  W S Mason; J M Taylor
Journal:  Hepatology       Date:  1989-04       Impact factor: 17.425

2.  Tissue preferential expression of the hepatitis B virus (HBV) surface antigen gene in two lines of HBV transgenic mice.

Authors:  R D Burk; J A DeLoia; M K elAwady; J D Gearhart
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

3.  A liver-specific enhancer in the core promoter region of human hepatitis B virus.

Authors:  J K Yee
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

4.  Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA.

Authors:  C Sureau; J L Romet-Lemonne; J I Mullins; M Essex
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

5.  Expression and replication of hepatitis B virus genome in transgenic mice.

Authors:  K Araki; J Miyazaki; O Hino; N Tomita; O Chisaka; K Matsubara; K Yamamura
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

6.  Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA.

Authors:  T Tsurimoto; A Fujiyama; K Matsubara
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

7.  Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice.

Authors:  T Moriyama; S Guilhot; K Klopchin; B Moss; C A Pinkert; R D Palmiter; R L Brinster; O Kanagawa; F V Chisari
Journal:  Science       Date:  1990-04-20       Impact factor: 47.728

8.  An in vitro system for infection with hepatitis B virus that uses primary human fetal hepatocytes.

Authors:  T Ochiya; T Tsurimoto; K Ueda; K Okubo; M Shiozawa; K Matsubara
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

9.  A novel expression selection approach allows precise mapping of the hepatitis B virus enhancer.

Authors:  A Tognoni; R Cattaneo; E Serfling; W Schaffner
Journal:  Nucleic Acids Res       Date:  1985-10-25       Impact factor: 16.971

10.  A human hepatitis B viral enhancer element.

Authors:  Y Shaul; W J Rutter; O Laub
Journal:  EMBO J       Date:  1985-02       Impact factor: 11.598

View more
  5 in total

Review 1.  Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes.

Authors:  Yuan-Chi Teng; Zhao-Qing Shen; Cheng-Heng Kao; Ting-Fen Tsai
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

2.  Production of antibody to hepatitis B surface antigen (anti-HBs) by murine hepatitis B virus carriers: neonatal tolerance versus antigen presentation by dendritic cells.

Authors:  K Kurose; S M Akbar; K Yamamoto; M Onji
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

3.  Characterization of T-cell tolerance to hepatitis B virus (HBV) antigen in transgenic mice.

Authors:  H Takashima; K Araki; J Miyazaki; K Yamamura; M Kimoto
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

4.  Transgenic expression of entire hepatitis B virus in mice induces hepatocarcinogenesis independent of chronic liver injury.

Authors:  Bing Na; Zhiming Huang; Qian Wang; Zhongxia Qi; Yongjun Tian; Cheng-Chan Lu; Jingwei Yu; Martha A Hanes; Sanjay Kakar; Eric J Huang; J-H James Ou; Limin Liu; T S Benedict Yen
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

5.  Sequence analysis of integrated hepatitis B virus DNA during HBeAg-seroconversion.

Authors:  Magdalena Agnieszka Budzinska; Nicholas Adam Shackel; Stephan Urban; Thomas Tu
Journal:  Emerg Microbes Infect       Date:  2018-08-08       Impact factor: 7.163

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.